How will you decide between using paclitaxel-coated balloons versus conventional uncoated balloons for managing in-stent restenosis?
1
1 Answers
Mednet Member
Cardiology · ETSU Health Care
Recent data (AGENT IDE trial) have suggested that target vessel failure rates are significantly lower in paclitaxel-coated balloons versus conventional balloon angioplasties when used to treat in-stent restenosis (ISR).
The drug-coated balloon for managing in-stent restenosis is a major step forward...